Your browser doesn't support javascript.
loading
The Great Deceiver: miR-2392's Hidden Role in Driving SARS-CoV-2 Infection
J. Tyson McDonald; Francisco Javier Enguita; Robert J Griffin; Waldemar Priebe; Mark R Emmett; Mohammad Sajadi; Anthony D Harris; Jean Clement; Nukhet Aykin-Burns; Peter Grabham; Stephen Baylin; Aliza Yousey; Andrea N Pearson; Peter M Corry; Amanda Saravia-Butler; Thomas R Aunins; Sadhana Sharma; Prashant Nagpal; Cem Meydan; Jonathan Foox; Christopher Mozsary; Bianca Cerqueira; Viktorija Zaksas; Urminder Singh; Eve Syrkin Wurtele; Sylvain V Costes; Gustavo Gastao Davanzo; Diego Galeano; Alberto Paccanaro; Suzanne L Meinig; Robert S Hagan; Natalie M Bowman; - UNC COVID-19 Pathobiology Consortium; Matthew C Wolfgang; Selin Altinok; Nicolae Sapoval; Todd J Treangen; Pedro M. Moraes-Vieira; Charles Vanderburg; Jonathan C Schisler; Christopher Mason; Anushree Chatterjee; Robert Meller; Afshin Beheshti.
Afiliación
  • J. Tyson McDonald; Georgetown University School of Medicine
  • Francisco Javier Enguita; Universidade de Lisboa
  • Robert J Griffin; University of Arkansas for Medical Sciences
  • Waldemar Priebe; University of Texas MD Anderson Cancer Center
  • Mark R Emmett; University of Texas Medical Branch, Galveston
  • Mohammad Sajadi; Institute of Human Virology at University of Maryland School of Medicine
  • Anthony D Harris; University of Maryland School of Medicine
  • Jean Clement; University of Maryland School of Medicine
  • Nukhet Aykin-Burns; University of Arkansas for Medical Sciences
  • Peter Grabham; Columbia University
  • Stephen Baylin; Johns Hopkins University, School of Medicine
  • Aliza Yousey; Morehouse School of Medicine
  • Andrea N Pearson; Morehouse School of Medicine
  • Peter M Corry; University of Arkansas for Medical Sciences
  • Amanda Saravia-Butler; Logyx, LLC, NASA Ames Research Center
  • Thomas R Aunins; University of Colorado Boulder
  • Sadhana Sharma; Sachi Bioworks Inc
  • Prashant Nagpal; University of Colorado Boulder
  • Cem Meydan; Weill Cornell Medicine
  • Jonathan Foox; Weill Cornell Medical College
  • Christopher Mozsary; Weill Cornell Medicine
  • Bianca Cerqueira; KBR Space & Science
  • Viktorija Zaksas; University of Chicago
  • Urminder Singh; Iowa State University
  • Eve Syrkin Wurtele; Iowa State University
  • Sylvain V Costes; NASA Ames Research Center
  • Gustavo Gastao Davanzo; University of Campinas
  • Diego Galeano; National University of Asuncion
  • Alberto Paccanaro; Fundacao Getulio Vargas
  • Suzanne L Meinig; University of North Carolina at Chapel Hill
  • Robert S Hagan; University of North Carolina at Chapel Hill
  • Natalie M Bowman; University of North Carolina at Chapel Hill
  • - UNC COVID-19 Pathobiology Consortium; -
  • Matthew C Wolfgang; University of North Carolina at Chapel Hill
  • Selin Altinok; The University of North Carolina at Chapel Hill
  • Nicolae Sapoval; Rice University
  • Todd J Treangen; Rice University
  • Pedro M. Moraes-Vieira; University of Campinas
  • Charles Vanderburg; Broad Institute of MIT and Harvard
  • Jonathan C Schisler; The University of North Carolina at Chapel Hill
  • Christopher Mason; Weill Cornell Medical College
  • Anushree Chatterjee; Sachi Bioworks Inc
  • Robert Meller; Morehouse School of Medicine
  • Afshin Beheshti; KBR, NASA Ames Research Center
Preprint en En | PREPRINT-BIORXIV | ID: ppbiorxiv-441024
ABSTRACT
MicroRNAs (miRNAs) are small non-coding RNAs involved in post-transcriptional gene regulation that have a major impact on many diseases and provides an exciting avenue towards antiviral therapeutics. From patient transcriptomic data, we have discovered a circulating miRNA, miR-2392, that is directly involved with SARS-CoV-2 machinery during host infection. Specifically, we show that miR-2392 is key in driving downstream suppression of mitochondrial gene expression, increasing inflammation, glycolysis, and hypoxia as well as promoting many symptoms associated with COVID-19 infection. We demonstrate miR-2392 is present in the blood and urine of COVID-19 positive patients, but not detected in COVID-19 negative patients. These findings indicate the potential for developing a novel, minimally invasive, COVID-19 detection method. Lastly, using in vitro human and in vivo hamster models, we have developed a novel miRNA-based antiviral therapeutic that targets miR-2392, significantly reduces SARS-CoV-2 viability in hamsters and may potentially inhibit a COVID-19 disease state in humans.
Licencia
cc_no
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-BIORXIV Idioma: En Año: 2021 Tipo del documento: Preprint
Texto completo: 1 Colección: 09-preprints Base de datos: PREPRINT-BIORXIV Idioma: En Año: 2021 Tipo del documento: Preprint